Metronomic and Targeted Anti-angiogenesis Therapy for Children With Recurrent/Progressive Medulloblastoma (MEMMAT)

This study is currently recruiting participants. (see Contacts and Locations)
Verified April 2015 by Medical University of Vienna
Medical University of Graz
Medical University Innsbruck
General Hospital Linz
Salzburger Landeskliniken
Information provided by (Responsible Party):
Andreas Peyrl, Medical University of Vienna Identifier:
First received: May 17, 2011
Last updated: April 24, 2015
Last verified: April 2015
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: April 2022
  Estimated Primary Completion Date: April 2019 (Final data collection date for primary outcome measure)